naftopidil and Cryptogenic Fibrosing Alveolitis

naftopidil has been researched along with Cryptogenic Fibrosing Alveolitis in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Endo, Y; Hiraishi, Y; Hosoki, K; Isago, H; Ishii, T; Kokuho, N; Kunugi, S; Makita, K; Matsuzaki, H; Mikami, Y; Mitani, A; Nagasaka, S; Nagase, T; Noguchi, S; Shimizu, A; Souma, K; Tamiya, H; Terasaki, M; Terasaki, Y; Urushiyama, H; Yamauchi, Y	1

Other Studies

1 other study(ies) available for naftopidil and Cryptogenic Fibrosing Alveolitis

Article	Year
Naftopidil reduced the proliferation of lung fibroblasts and bleomycin-induced lung fibrosis in mice. Journal of cellular and molecular medicine, 2019, Volume: 23, Issue:5 Topics: Adrenergic alpha-Antagonists; Animals; Bleomycin; Cell Cycle; Cell Line; Cell Proliferation; Cells, Cultured; Fibroblasts; Humans; Idiopathic Pulmonary Fibrosis; Lung; Mice, Inbred C57BL; Naphthalenes; Piperazines; Pulmonary Surfactant-Associated Protein D; X-Ray Microtomography	2019

Article

Year

Naftopidil reduced the proliferation of lung fibroblasts and bleomycin-induced lung fibrosis in mice.

Journal of cellular and molecular medicine, 2019, Volume: 23, Issue:5

Topics: Adrenergic alpha-Antagonists; Animals; Bleomycin; Cell Cycle; Cell Line; Cell Proliferation; Cells, Cultured; Fibroblasts; Humans; Idiopathic Pulmonary Fibrosis; Lung; Mice, Inbred C57BL; Naphthalenes; Piperazines; Pulmonary Surfactant-Associated Protein D; X-Ray Microtomography

2019